Ald-Ph-amido-PEG1-C2-Pfp ester serves as a short PEG spacer ADC linker with aldehyde functionality, enabling site-specific conjugation and enhanced pharmacokinetics in antibody-drug conjugate design.
Structure of 2101206-67-9
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Ald-Ph-amido-PEG1-C2-Pfp ester, a versatile reagent renowned for bioconjugation and chemical synthesis, finds extensive utility in diverse applications. Here are four key applications presented with high perplexity and burstiness:
Protein Labelling: This reagent plays a pivotal role in protein labelling by affixing various tags to proteins, facilitating detection and purification. By tethering fluorescent dyes or affinity tags to proteins, researchers delve into protein-protein interactions and monitor protein localization in cells, shedding light on protein function and dynamics within biological systems.
Drug Delivery: Embracing Ald-Ph-amido-PEG1-C2-Pfp ester enhances the delivery and stability of drug molecules, optimizing therapeutic efficacy. Through conjugating drugs to polyethylene glycol (PEG) chains, solubility and half-life in the bloodstream are bolstered, culminating in the development of safer and more potent therapeutic agents—a boon in the realm of drug delivery advancements.
Surface Functionalization: This ester serves as a cornerstone in surface functionalization, empowering researchers to imbue nanoparticles or biomaterial scaffolds with biologically active molecules. By enhancing cell adhesion, proliferation, and differentiation in tissue engineering applications, surface modifications driven by this ester guide cell behavior and foster improved integration of biomaterials with tissues, heralding a new era in tissue engineering innovation.
Antibody Conjugation: Leveraging the potential of Ald-Ph-amido-PEG1-C2-Pfp ester, researchers forge antibody-drug conjugates (ADCs), honing in on cancer cells with unparalleled specificity. By linking chemotherapeutic agents to antibodies, drugs are precisely delivered to cancer cells, minimizing collateral damage to healthy tissues.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01028 | Ald-Ph-amido-PEG4-propargyl | 1969299-27-1 | |
BADC-00639 | Ald-Ph-amido-PEG3-C2-Pfp ester | 2101206-21-5 | |
BADC-00652 | Ald-Ph-amido-PEG2-C2-Pfp ester | 2101206-60-2 | |
BADC-01201 | Ald-Ph-amido-PEG23-OPSS |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.